https://www.selleckchem.com/pr....oducts/orforglipron-
3%. There were 37 discordant samples including 30 with BD RPR+/BioPlex RPR- and 7 with BD RPR-/BioPlex RPR+. Negative BioPlex RPR results were observed in samples with reactive BD RPR 10 out of 11 (91%) for BD RPR 11, 13 out of 20 (65%) for BD RPR 12, 6 out of 17 (35%) for BD RPR 14 and 1 out of 14 (7%) for BD RPR 18. The discordant samples were predominantly from patients with high-risk of syphilis reinfection and included nine patients with an early reinfection. CONCLUSIONS Our results demonstrated that BioPlex Syphilis